Invetx
Rebecca Sendak has more than 20 years of experience in biologics CMC (chemistry, manufacturing, and controls) at Genzyme and Sanofi, from cell line development through GMP drug product manufacturing. Supported the development and commercialization of several biologics currently on the market. She is also the Head (SVP) of the Global Large Molecules Research Platform at Sanofi.
Rebecca holds a Ph.D. in Biophysical Chemistry from Cornell University and received a Bachelor of Arts in Biology and Chemistry from the University of Vermont.
This person is not in the org chart
This person is not in any offices
Invetx
At Invetx, they bring the best of biopharma to animal health. Their network includes experts in both animal and human health, veterinary scientists, and clinicians. Their vision is of a global animal health industry that fully leverages biopharma technologies to deliver dramatically improved health outcomes for pets and farm animal populations.